1. Apter, F.M., Lencer, W.I., Finkelstein, R.A., Mekalanos, J.J. and Neutra, M.R. (1993a) Monoclonal immunoglobulin A antibodies directed against cholera toxin prevent the toxin-induced chloride secretory response and block toxin binding to intestinal epithelial cells in vitro. Infection and Immunity, 61, 5271–8.
2. Apter, F.M., Michetti, P., Winner, L.S. III, Mack, J.A., Mekalanos, J.J. and Neutra, M.R. (1993b) Analysis of the roles of anti-lipopolysaccharide and anti-cholera toxin immunoglobulin A (IgA) antibodies in protection against Vibrio cholerae and cholera toxin by use of monoclonal IgA antibodies in vivo. Infection and Immunity, 61, 5279–85.
3. Attridge, S.R. and Rowley, D. (1983) Prophylactic significance of nonlipopoly-saccharide antigens of Vibrio cholerae. Journal of Infectious Diseases, 148, 931–9.
4. Attridge, S.R., Daniels, D., Morona, J.K. and Morona, R. (1990) Surface co-expression of Vibrio cholerae and Salmonella typhi O-antigens on Ty21a clone EX210. Microbial Pathogenesis, 8, 177–88.
5. Bartholomeusz, R.C.A., Forrest, B.D., LaBrooy, J.T., Ey, P.L., Pyle, D., Shearman, D.J.C. and Rowley, D. (1990) The serum polymeric IgA antibody response to typhoid vaccination; its relationship to the intestinal IgA response. Immunology, 69, 190–4.